Baker Bros. Advisors Lp Incyte Corp (INCY) insider trading activity

BAKER BROS. ADVISORS LP Transaction History

Date	Transaction	Value	Shares Traded
Sep 30 2024	BUY Grant, award, or other acquisition	-	992
Jun 28 2024	BUY Grant, award, or other acquisition	-	1,074
Jun 12 2024	SELL Sale (or disposition) back to the issuer	$327,550,980 $60.0 p/Share	5,459,183
Jun 12 2024	BUY Grant, award, or other acquisition	-	5,660
May 07 2024	BUY Exercise of conversion of derivative security	$1,470,300 $49.01 p/Share	30,000
Mar 28 2024	BUY Grant, award, or other acquisition	-	1,086
Dec 29 2023	BUY Grant, award, or other acquisition	-	1,112
Sep 29 2023	BUY Grant, award, or other acquisition	-	1,020
Jun 30 2023	BUY Grant, award, or other acquisition	-	1,024
Jun 14 2023	BUY Grant, award, or other acquisition	-	5,010
Mar 31 2023	BUY Grant, award, or other acquisition	-	858
Mar 13 2023	BUY Exercise of conversion of derivative security	$909,599 $22.74 p/Share	40,000
Dec 30 2022	BUY Grant, award, or other acquisition	-	794
Sep 30 2022	BUY Grant, award, or other acquisition	-	914
Jun 30 2022	BUY Grant, award, or other acquisition	-	866
Jun 15 2022	BUY Grant, award, or other acquisition	-	4,288
Mar 31 2022	BUY Grant, award, or other acquisition	-	880
Mar 10 2022	BUY Open market or private purchase	$15,821,775 $72.39 p/Share	218,563
Mar 09 2022	BUY Open market or private purchase	$5,057,479 $71.72 p/Share	70,517
Mar 08 2022	BUY Open market or private purchase	$7,067,000 $70.67 p/Share	100,000
Mar 08 2022	BUY Exercise of conversion of derivative security	$882,000 $22.05 p/Share	40,000
Feb 22 2022	BUY Open market or private purchase	$6,793,386 $68.07 p/Share	99,800
Feb 18 2022	BUY Open market or private purchase	$9,099,389 $68.4 p/Share	133,032
Feb 17 2022	BUY Open market or private purchase	$19,793,188 $67.56 p/Share	292,972
Feb 14 2022	BUY Open market or private purchase	$33,203,317 $66.03 p/Share	502,852

Also insider at

GHDX

GENOMIC HEALTH INC

Director

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

BGNE

BeiGene, Ltd. Healthcare

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

MRTX

Mirati Therapeutics, Inc. Healthcare

BLCM

BELLICUM PHARMACEUTICALS, INC Healthcare

> 10% Shareholder

SGEN

Seagen Inc. Healthcare

Director

NVTA

Invitae Corp Healthcare

> 10% Shareholder

ALXN

ALEXION PHARMACEUTICALS, INC.

Director

NLTX

Neoleukin Therapeutics, Inc. Healthcare

Director

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

KOD

Kodiak Sciences Inc. Healthcare

HOOK

HOOKIPA Pharma Inc. Healthcare

BCEL

Atreca, Inc. Healthcare

IGMS

IGM Biosciences, Inc. Healthcare

ZYME

Zymeworks Inc. Healthcare

Director

PRLD

Prelude Therapeutics Inc Healthcare

TLIS

Talis Biomedical Corp Healthcare

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

TCRX

TScan Therapeutics, Inc. Healthcare

TRDA

Entrada Therapeutics, Inc. Healthcare

DBVT

DBV Technologies S.A. Healthcare

Director

MDGL

MADRIGAL PHARMACEUTICALS, INC. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

KYMR

Kymera Therapeutics, Inc. Healthcare

BCYC

BICYCLE THERAPEUTICS plc Healthcare

IMCR

Immunocore Holdings plc Healthcare

BBA